The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: 0.00 (0.00%)
Spread: 2.00 (0.017%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

TREASURIES-U.S. yields little changed on caution about stimulus package

Tue, 26th Jan 2021 15:48

By Gertrude Chavez-Dreyfuss
NEW YORK, Jan 26 (Reuters) - U.S. Treasury yields were
little changed to slightly higher in choppy trading on Tuesday,
after hitting three-week lows on the long end of the curve, as
investors remained cautious in the near term about the size of a
proposed U.S. stimulus package as well as the slow global
roll-out of coronavirus vaccines.
The U.S yield curve steepened modestly after flattening on
Monday. The spread between U.S. two-year and 10-year yields
widened modestly to 91.50 basis points.
U.S. Senate Majority Leader Chuck Schumer said late on
Monday that he and his fellow Democrats may try to pass much of
President Joe Biden's $1.9 trillion coronavirus relief bill
using a process that would bypass a Republican filibuster and
could allow it to pass with a majority vote.
"We think ultimately it's going to be smaller than the $1.9
trillion," said Mike Chang, interest rates strategist at Citi in
New York. "We have penciled in around $600 billion-$1 trillion.
Timing is another issue, not just the size - how long it will
take to get the whole thing through."
In addition, there have been coronavirus vaccine delivery
problems globally, especially in Europe.
AstraZeneca, which developed its vaccine with Oxford
University, told the European Union that it could not meet
agreed supply targets by the end of March. Pfizer Inc
said there would be a temporary impact on shipments of its
vaccine in late January to early February.
In mid-morning trading, the U.S. benchmark 10-year yield
fell to 1.33%, from 1.04% late on Monday. It earlier
fell to 1.026%, its lowest level since Jan. 6.
U.S. 30-year yields slid to 1.7955% from
Monday's 1.799%, after earlier dropping to a three-week low of
1.786%.
U.S. 20-year bond yields also weakened to a
three-week trough and were last down at 1.59%.
On the front end of the curve, U.S. two-year yields slipped
to 0.121% from 0.127% on Monday.
Also on Tuesday, the Treasury auctions a record $61 billion
in 5-year notes after a solid 2-year debt sale on Monday.
"We believe there will be demand as the Treasury market has
had a firm tone in recent sessions," Justin Lederer, rates
strategist at Cantor Fitzgerald, said in a research note.
"We, however, would not be surprised by a small back-up
leading into 1 pm (bid deadline) and/or small tail as market
participants are cautious at the current yield levels, as the
sector is trading at its richest levels since early January and
12 basis points lower than its high yield print a few weeks
ago," he added.
Ahead of the auction, U.S. five-year note yields were little
changed at 0.4119%.

January 26 Tuesday 10:28AM New York / 1528 GMT
Price Current Net
Yield % Change
(bps)
Three-month bills 0.08 0.0811 0.000
Six-month bills 0.085 0.0862 -0.003
Two-year note 100-1/256 0.123 -0.004
Three-year note 99-214/256 0.1805 0.000
Five-year note 99-210/256 0.4119 0.002
Seven-year note 99-80/256 0.727 0.002
10-year note 98-116/256 1.0414 0.001
20-year bond 96-12/256 1.6089 0.005
30-year bond 95-236/256 1.8024 0.003

DOLLAR SWAP SPREADS
Last (bps) Net
Change
(bps)
U.S. 2-year dollar swap 7.50 -0.25
spread
U.S. 3-year dollar swap 8.25 0.25
spread
U.S. 5-year dollar swap 10.00 0.50
spread
U.S. 10-year dollar swap 3.25 0.25
spread
U.S. 30-year dollar swap -24.00 0.00
spread


(Reporting by Gertrude Chavez-Dreyfuss
Editing by Paul Simao)

More News
5 Apr 2024 07:23

AstraZeneca announces positive lung cancer treatment trial results

(Sharecast News) - AstraZeneca announced positive high-level results from a phase three trial demonstrating significant advancements in the treatment of limited-stage small cell lung cancer (LS-SCLC) on Friday.

Read more
4 Apr 2024 13:09

UK shareholder meetings calendar - next 7 days

Friday 5 April 
Faron Pharmaceuticals LtdAGM
VPC Specialty Lending Investments PLCGM re capital return via B share scheme
Monday 8 April 
Premier African Minerals LtdAGM
Tuesday 9 April 
Ethernity Networks LtdEGM re board appointments and option grants
Wednesday 10 April 
Valereum PLCAGM
Wincanton PLCGM re takeover by GXO Logistics Inc
Thursday 11 April 
AstraZeneca PLCAGM
  
Comments and questions to newsroom@alliancenews.com
  
A full 21-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
3 Apr 2024 22:01

Biden, Senator Bernie Sanders push companies to cut cost of asthma inhalers, prescription drugs

WASHINGTON, April 3 (Reuters) - President Joe Biden hosted a White House event with U.S. Senator Bernie Sanders on Wednesday to tout their fight against high prescription drug prices and push companies to cut the cost of inhalers for asthma sufferers.

Read more
3 Apr 2024 17:22

UK's FTSE 100 pressured by stronger pound; miners climb

FTSE 100 flat, FTSE 250 up 0.2%

*

Read more
3 Apr 2024 11:02

CORRECT: AstraZeneca, Daiichi make US progress with licence approvals

(Correcting the description of extravascular haemolysis' effects on patients with paroxysmal nocturnal haemoglobinuria)

Read more
2 Apr 2024 15:22

London close: Stocks turn red on return from Easter break

(Sharecast News) - UK stocks experienced a downturn by the end of trading on Tuesday, as investors resumed activity following the extended weekend, with initial gains reversed by the close ahead of a week marked by a number of key economic data releases.

Read more
2 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 buoyed by UK manufacturing growth

(Alliance News) - The FTSE 100 in London was up at midday on Tuesday, reacting to the UK manufacturing sector returning growth and further PMI data across the globe.

Read more
2 Apr 2024 10:25

AstraZeneca and Daiichi make US progress with latest licence approvals

(Alliance News) - AstraZeneca PLC on Tuesday noted significant progress for two of its clinical-stage treatments in the US.

Read more
2 Apr 2024 09:54

LONDON BROKER RATINGS: Bernstein starts AstraZeneca at 'outperform'

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
2 Apr 2024 09:09

LONDON MARKET OPEN: FTSE 100 up as oil majors and gold miners shine

(Alliance News) - Stock prices in London opened higher on Tuesday, in confident trade following the long Easter weekend, ahead of a UK manufacturing sector reading later in the morning.

Read more
2 Apr 2024 08:05

LONDON BRIEFING: HSBC in special payout on Canada sale; Astra FDA win

(Alliance News) - London's FTSE 100 traded higher on Tuesday following the long weekend, as investors react to US data, and look ahead to manufacturing sector readings from Europe later.

Read more
2 Apr 2024 07:08

US FDA gives green light for use of AstraZeneca's Voydeva

(Sharecast News) - America's drug regulator gave the green light to AstraZeneca's for the add-on use of Voydeya in the treatment of extravascular haemolysis (EVH) in patients with paroxysmal nocturnal haemoglobinuria (PNH).

Read more
27 Mar 2024 12:02

LONDON MARKET MIDDAY: FTSE 100 underperforms ahead of US PCE data

(Alliance News) - Stock prices in London were lower at midday on Wednesday, but trade was more confident in mainland Europe, with focus turning to the release of the US Federal Reserve's preferred inflation gauge on Friday.

Read more
27 Mar 2024 11:56

C4X Discovery seeks AIM delisting but half-year revenue skyrockets

(Alliance News) - C4X Discovery Holdings PLC shares plunged on Wednesday after it said it plans to delist from AIM in London, due to "the recent downturn in the financial markets" hampering its valuation.

Read more
27 Mar 2024 09:19

AstraZeneca treatments become "first and only" to be approved in Japan

(Alliance News) - AstraZeneca PLC announced on Wednesday the approval of two of its treatments for use in Japan.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.